Published in J Soc Gynecol Investig on February 01, 2005
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.06
Sex steroid-related candidate genes in psychiatric disorders. J Psychiatry Neurosci (2008) 0.88
Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women. Cancer Epidemiol (2010) 0.85
Androgen receptor gene and sex-specific Alzheimer's disease. Neurobiol Aging (2013) 0.83
Androgen receptor (CAG)n polymorphism and androgen levels in women with systemic lupus erythematosus and healthy controls. Rheumatol Int (2013) 0.80
Androgen receptor CAG repeat length and risk of biliary tract cancer and stones. Cancer Epidemiol Biomarkers Prev (2010) 0.78
Childhood obesity. J Clin Endocrinol Metab (2004) 2.29
Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab (2002) 2.13
Apparent male gender identity in a patient with complete androgen insensitivity syndrome. Arch Sex Behav (2009) 2.01
Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab (2007) 1.71
Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study. J Clin Endocrinol Metab (2004) 1.61
Ovarian volume in pre- and perimenopausal women: a population-based study. Menopause (2003) 1.54
Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome. Fertil Steril (2004) 1.39
Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. J Clin Endocrinol Metab (2013) 1.39
Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry (2002) 1.34
Activating mutations of Gsalpha in kidney cancer. J Urol (2006) 1.31
Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod (2007) 1.27
Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab (2010) 1.21
Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and antiandrogen activity in reporter cell lines. Mol Cell Endocrinol (2002) 1.16
Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab (2006) 1.13
Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative study. J Clin Endocrinol Metab (2008) 1.12
Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children. J Urol (2008) 1.08
Hypospadias: etiology and current research. Urol Clin North Am (2010) 1.06
Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? Int J Androl (2008) 1.06
Association between habitual physical activity and lower cardiovascular risk in premenopausal, perimenopausal, and postmenopausal women: a population-based study. Menopause (2013) 1.04
Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril (2007) 1.02
The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency. Horm Res Paediatr (2010) 1.01
Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause (2006) 1.01
Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism (2008) 0.99
How subchronic and chronic health effects can be neglected for GMOs, pesticides or chemicals. Int J Biol Sci (2009) 0.99
Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentration. Reprod Biol Endocrinol (2010) 0.97
Mutations of CXorf6 are associated with a range of severities of hypospadias. Eur J Endocrinol (2008) 0.95
Molecular analysis of WNT4 gene in four adolescent girls with mullerian duct abnormality and hyperandrogenism (atypical Mayer-Rokitansky-Küster-Hauser syndrome). Fertil Steril (2011) 0.95
Effects of physical activity on bone remodeling. Metabolism (2010) 0.94
Vitamin D deficiency in girls from South Brazil: a cross-sectional study on prevalence and association with vitamin D receptor gene variants. BMC Pediatr (2012) 0.94
Prevalence of hypospadias in grandsons of women exposed to diethylstilbestrol during pregnancy: a multigenerational national cohort study. Fertil Steril (2011) 0.93
Effect of physical activity on calcium homeostasis and calciotropic hormones: a review. Calcif Tissue Int (2009) 0.93
Determinants of ovarian volume in pre-, menopausal transition, and post-menopausal women: a population-based study. Maturitas (2005) 0.93
Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case-control study. Hum Reprod (2011) 0.91
Menopause, estrogens, and endothelial dysfunction: current concepts. Clinics (Sao Paulo) (2007) 0.91
Ambiguous genitalia in the newborn. Semin Reprod Med (2002) 0.90
Complete androgen insensitivity syndrome is frequently due to premature stop codons in exon 1 of the androgen receptor gene: an international collaborative report of 13 new mutations. Fertil Steril (2009) 0.90
Ovarian and uterine findings in pelvic sonography: comparison between prepubertal girls, girls with isolated thelarche, and girls with central precocious puberty. J Ultrasound Med (2002) 0.90
Endocrine disorders in adolescent and young female athletes: impact on growth, menstrual cycles, and bone mass acquisition. J Clin Endocrinol Metab (2014) 0.89
Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome. Fertil Steril (2011) 0.89
Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials. J Clin Endocrinol Metab (2014) 0.88
Appendicular skeletal muscle mass is the strongest independent factor associated with femoral neck bone mineral density in adult and older men. Exp Gerontol (2010) 0.88
Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines. Mol Cell Endocrinol (2002) 0.88
A new recombinant cell bioassay for ultrasensitive determination of serum estrogenic bioactivity in children. J Clin Endocrinol Metab (2002) 0.87
Coexpression of Wilms' tumor suppressor 1 (WT1) and androgen receptor (AR) in the genital tract of human male embryos and regulation of AR promoter activity by WT1. J Mol Endocrinol (2007) 0.87
Circulating leptin concentrations can be used as a surrogate marker of fat mass in acute spinal cord injury patients. Metabolism (2004) 0.87
Clinical, biological and genetic analysis of prepubertal isolated ovarian cyst in 11 girls. PLoS One (2010) 0.87
Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals. Environ Health Perspect (2004) 0.87
Bone remodeling and calcium homeostasis in patients with spinal cord injury: a review. Metabolism (2011) 0.86
Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study. Horm Res Paediatr (2013) 0.86
[Molecular biology in the prostate neoplasia]. Arq Bras Endocrinol Metabol (2006) 0.86
Familial frameshift SRY mutation inherited from a mosaic father with testicular dysgenesis syndrome. J Clin Endocrinol Metab (2009) 0.86
An N-terminal WT1 mutation (P181S) in an XY patient with ambiguous genitalia, normal testosterone production, absence of kidney disease and associated heart defect: enlarging the phenotypic spectrum of WT1 defects. Eur J Endocrinol (2004) 0.86
Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women. Menopause (2012) 0.86
Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome. Int J Pediatr Endocrinol (2012) 0.86
Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J Clin Endocrinol Metab (2004) 0.86
Predominant Sertoli cell deficiency in a 46,XY disorders of sex development patient with a new NR5A1/SF-1 mutation transmitted by his unaffected father. Fertil Steril (2010) 0.85
Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty. J Pediatr Endocrinol Metab (2008) 0.85
Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. Fertil Steril (2013) 0.85
Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. Hum Mol Genet (2006) 0.84
[Current aspects on diagnosis and treatment of endometriosis]. Rev Bras Ginecol Obstet (2010) 0.84
Premature pubarche in Mediterranean girls: high prevalence of heterozygous CYP21 mutation carriers. Gynecol Endocrinol (2010) 0.84
Isolated Cushing's syndrome: an unusual presentation of McCune-Albright syndrome in the neonatal period. Horm Res (2009) 0.84
Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes. Fertil Steril (2010) 0.84
c-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action. J Mol Histol (2009) 0.84
Pediatric and adolescent gynecology. Evidence-based clinical practice. Preface. Endocr Dev (2004) 0.83
Ovarian and uterine sonography in healthy girls between 1 and 13 years old: correlation of findings with age and pubertal status. AJR Am J Roentgenol (2002) 0.83
Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause. Fertil Steril (2008) 0.82
Specific bone mass acquisition in elite female athletes. J Clin Endocrinol Metab (2013) 0.82
Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter? Fertil Steril (2012) 0.82
Bone mass acquisition in female rhythmic gymnasts during puberty: no direct role for leptin. Clin Endocrinol (Oxf) (2009) 0.82
NR5A1 (SF-1) gene variants in a group of 26 young women with XX primary ovarian insufficiency. Fertil Steril (2012) 0.82
Primary amenorrhea in a young Polish woman with complete androgen insensitivity syndrome and Sertoli-Leydig cell tumor: identification of a new androgen receptor gene mutation and evidence of aromatase hyperactivity and apoptosis dysregulation within the tumor. Gynecol Endocrinol (2007) 0.82
Glutamic acid 709 substitutions highlight the importance of the interaction between androgen receptor helices H3 and H12 for androgen and antiandrogen actions. Mol Endocrinol (2005) 0.82
Screening of MAMLD1 mutations in 70 children with 46,XY DSD: identification and functional analysis of two new mutations. PLoS One (2012) 0.82
Oxytocin promotes bone formation during the alveolar healing process in old acyclic female rats. Arch Oral Biol (2012) 0.81
Minor hypospadias: the "tip of the iceberg" of the partial androgen insensitivity syndrome. PLoS One (2013) 0.81